Biotech Co.* |
Pharma Co. |
Product | Terms/Details (Date) |
Advancis |
Innovex (unit of Quintiles Transnational Corp.) |
Innovex will provide sales and marketing services for Advancis' cephalosporin antibiotic, Keflex capsules |
Innovex will deploy 75 sales representatives to sell and promote the recently approved product under a two-year deal; terms were not disclosed (6/22) |
Amaxa GmbH* |
Dharmacon Inc. |
Deal to co-promote data generated using Dharmacon's siRNA libraries with Amaxa's Nucleofector technology |
The focus is on delivery of siRNA into primary cells and non-standard cell lines; terms of the deal were not disclosed (6/6) |
Antigenics |
GlaxoSmithKline Biologicals (Belgium) |
They expanded deal under which Antigenics supplies QS-21 Stimulon adjuvant for use in GSK vaccines |
Antigenics also will transfer manufacturing technologies to GSK under the agreement; Antigenics is entitled to milestone and royalty payments in the deal (7/10) |
Cephalon |
Takeda Pharmaceuticals North America Inc. |
Takeda will co-promote Cephalon's Provigil in the U.S. (and Nuvigil, if approved) |
Takeda will provide 500 sales reps, adding to the 400 from Cephalon; Takeda is entitled to royalties under the three-year, renewable deal (6/12) |
Generex |
Cardinal Health Inc. |
Deal under which Cardinal will manufacture clinical-trial batches of Generex's Oral-lyn insulin spray product |
Terms of the deal were not disclosed (6/22) |
Genomatica Inc.* |
DSM Biologics (the Netherlands) |
Multiyear deal under which Genomatica will help DSM develop improved biological processes |
The deal centers around implementation of Genomatica's metabolic modeling and simulation technologies; Genomatica is entitled to license fees, R&D payments and milestone payments in the deal (6/28) |
Nastech |
Procter & Gamble Pharmaceuticals Inc. |
Nastech will manufacture PTH1-34 nasal spray for P&G |
The supply agreement is in addition to a collaboration on the parathyroid hormone-based product the companies entered in February (6/6) |
SciClone |
Biocompatibles International plc (UK) |
SciClone got exclusive rights to market Biocompatibles' DC Bead chemotherapy-releasing device in China |
A submission for approval in China is planned during 2006; terms of the three- year deal were not disclosed (6/9) |
Stellar |
Bio-Technic Romania Srl (Romania) |
Bio-Technic got rights to the hyaluronate-based product NeoVisc in Romania |
The product is used to treat the pain of osteoarthritis; terms of the deal were not disclosed (7/13) |
Tercica Inc. |
Biologix FZ Co. (Lebanon) and Giddi Pharma Co. (Taiwan) |
Separate deals were entered covering the distribution of Tercica's growth hormone product Increlex |
Biologix FZ will distribute the product in 17 Middle East and North African countries, and Giddi will distribute it in Taiwan; terms were not disclosed (6/14) |
Tm Bioscience |
Sanbio BV (the Netherlands) |
Sanbio will commercialize the ID-Tag Respiratory Viral Panel in the Netherlands |
The product is used in the diagnosis of respiratory viruses; terms of the distribution deal were not disclosed (6/16) |
Notes: | |||
# The information in the chart does not cover agricultural agreements or those between biotech companies. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
CDNX = Canadian Venture Exchange; TSE = Toronto Stock Exchange. | |||
To read more on related topics, click on one of the words below.